ICON has been conducting clinical studies for over 25 years and our reputation for safety, scientific integrity and compliance allows us to enjoy a first class reputation with clients from major pharmaceutical companies and volunteers who participate in our studies.

The safety of volunteers is our primary concern. All our studies are conducted under internationally agreed guidelines set down by the US Food and Drug Administration (FDA) and the UK Medicine and Healthcare Products Regulatory Agency (MHRA). Each study is reviewed by an Independent Ethics Committee which is responsible for ensuring that your safety has been thoroughly considered, that the information provided to you is fair, balanced and accurate and that your rights as a volunteer are maintained.

We really do value our volunteers who we rely on to help with our studies. In return for your time and commitment you will be compensated up to £3500! Although our volunteers are compensated financially, many take part because they’re keen to help the world of medicine progress new treatments which may improve the quality of life of people all over the world.

Sign up today...do Something To Be Proud Of.

Note: From 23rd June, 2009, clinical trial activity will no longer take place at our unit in Skelton House, Manchester Park. We are pleased to announce that we will be relocating our Clinical Pharmacology Unit (CPU) to a new purpose built facility on the Central Manchester University Hospitals campus, which is due for completion by April 2012.

Between now and April 2010, we plan to use the clinical facilities at our partner sites which will be in the Manchester or London areas. From April 2010 until the opening of our purpose built CPU we will also be conducting our trials from dedicated clinical research facilities on the Manchester Royal Infirmary site.